Single Assets

Better to keep than pass the parcel – the timely case for CVs

Critics argue CVs entrench managers or delay inevitable exits. However, structured with transparency and fairness, these funds align interests rather than obscure them, writes AEA Investors’ and Painswick Capital’s John Garcia.

While tiered carry boosts pricing and alignment, ILPA urges caution

Variable profit-sharing structures are designed to foster alignment between sponsors and secondaries buyers – but an influential LP group says investors should be wary.

LPs believe there is room for improvement in infra CVs – II Global Summit

While infrastructure CVs tend to be completed at or above fair market price, LPs are doubtful that these deals mark the best price that could be achieved, according to panellists at PEI Group’s Infrastructure Investor Global Summit 2026.

Lead Edge’s latest flagship taps secondaries amid AI-driven shifts

The firm’s seventh fund may invest across a wide range of secondaries strategies.

Jefferies brings on senior GP-led talent from Lazard

People moves within the secondaries advisory community have continued apace as firms jockey for competitive position.

Carlyle AlpInvest leads on TowerBrook’s CV for EisnerAmper

TowerBrook has ‘spent considerable money, time and resources’ transforming the professional services business across its four-plus year hold, managing director Walter Weil tells Secondaries Investor.

QHP’s pharma single-asset delivers 10x for selling LPs

This is at least the second time the mid-market healthcare-focused firm has run a CV to extend its hold of a top-performing asset.

CVs should be structured in an ‘LP-friendly’ way: Lexington’s Christophe Browne

A higher percentage of LPs choosing to roll into CVs would be a ‘healthy’ sign for the market, Lexington Partners’ Christophe Browne said at NEXUS 2026.

Next Gen alumni on the future of GP-led secondaries

From CVs on CVs to greater specialisation, secondaries professionals who have previously featured on our rising stars list share their insights on the market’s evolution.

Edmond de Rothschild Corporate Finance and Jasmin Capital form partnership for CVs

The investment bank and placement agent will together focus on co-control deals where GPs are seeking to sell part of a stake via M&A and move the remainder into a CV.